Myeloid Cell Leukemia-1 Is an Important Apoptotic Survival Factor in Triple-Negative Breast Cancer

Cell Death and Differentiation - United Kingdom
doi 10.1038/cdd.2015.73
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

ERR Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Triple-Negative Breast Cancer

2018English

The WNT10B Network Is Associated With Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer

Cancer Research
Cancer ResearchOncology
2018English

Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2013English

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer

Frontiers in Medicine
Medicine
2019English

Triple-Negative Breast Cancer: An Unmet Medical Need

Oncologist
Cancer ResearchMedicineOncology
2011English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

SIK2 Restricts Autophagic Flux to Support Triple-Negative Breast Cancer Survival

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2016English

T‑cadherin Is Associated With Prognosis in Triple‑negative Breast Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy